Latanoprostene bunod allows for greater IOP lowering vs latanoprost by approximately how many mmHg?

Boost your readiness for the Primary Open-Angle Glaucoma Test. Utilize flashcards and multiple-choice questions complete with hints and detailed explanations to enhance your understanding.

Multiple Choice

Latanoprostene bunod allows for greater IOP lowering vs latanoprost by approximately how many mmHg?

Explanation:
Two mechanisms drive the extra IOP lowering with latanoprostene bunod compared with latanoprost: the prostaglandin-like effect that increases uveoscleral outflow, and the nitric oxide donor component that relaxes the trabecular meshwork to boost outflow through the conventional pathway. The combination yields an average additional lowering of about 1.2 mmHg. This is the typical difference reported in clinical trials, while other values tend to be outside the expected range. So, the best answer reflects roughly a 1.2 mmHg extra reduction.

Two mechanisms drive the extra IOP lowering with latanoprostene bunod compared with latanoprost: the prostaglandin-like effect that increases uveoscleral outflow, and the nitric oxide donor component that relaxes the trabecular meshwork to boost outflow through the conventional pathway. The combination yields an average additional lowering of about 1.2 mmHg. This is the typical difference reported in clinical trials, while other values tend to be outside the expected range. So, the best answer reflects roughly a 1.2 mmHg extra reduction.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy